CLOVER HEALTH INVESTMENTS, CORP. /DE Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value
CLOVER HEALTH INVESTMENTS, CORP. /DE (CLOV) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value of $0 for the 12-month period ending 2021-12-31, per its 10-K filed 2022-02-28.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodTotalFairValue · last filed 2022-02-28
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for the quarter ending 2021-12-31 was $0.00, a 100.00% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for the quarter ending 2021-09-30 was $0.00, a 100.00% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for the quarter ending 2021-06-30 was $0.00, a 100.00% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for the quarter ending 2021-03-31 was $0.00, a 100.00% decline year-over-year.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for fiscal 2021 was $0.00, a 100.00% decline from fiscal 2020.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for fiscal 2020 was $7.00M, a 677.78% increase from fiscal 2019.
- CLOVER HEALTH INVESTMENTS, CORP. /DE share-based compensation arrangement by share-based payment award, equity instruments other than options, vested in period, fair value for fiscal 2019 was $900.00K.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Fair Value 12 month |
|---|---|---|---|---|
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $0.00 derived: sum of 2 quarters · filed 2022-02-28 | $0.00 derived: sum of 3 quarters · filed 2022-02-28 | $0.00 10-K · filed 2022-02-28 |
| 2021-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $0.00 derived: sum of 2 quarters · filed 2021-11-09 | $0.00 10-Q · filed 2021-11-09 | $3.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $0.00 10-Q · filed 2021-08-11 | $3.00M derived: sum of 3 quarters · filed 2022-02-28 | $5.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2021-03-31 | $0.00 10-Q · filed 2021-05-17 | $3.00M derived: sum of 2 quarters · filed 2022-02-28 | $5.00M derived: sum of 3 quarters · filed 2022-02-28 | $6.00M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-12-31 | $3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | $5.00M derived: sum of 2 quarters · filed 2022-02-28 | $6.00M derived: sum of 3 quarters · filed 2022-02-28 | $7.00M 10-K · filed 2022-02-28 |
| 2020-09-30 | $2.00M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $3.00M derived: sum of 2 quarters · filed 2021-11-09 | $4.00M 10-Q · filed 2021-11-09 | |
| 2020-06-30 | $1.00M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-11 | $2.00M 10-Q · filed 2021-08-11 | ||
| 2020-03-31 | $1.00M 10-Q · filed 2021-05-17 | |||
| 2019-12-31 | $900.00K 10-K · filed 2022-02-28 |